- Nachrichtendetail
-
26.04.2024 14:37:45 - dpa-AFX: *TAKEDA'S FRUQUINTINIB GETS CHMP OPINION FOR PREVIOUSLY TREATED METASTATIC COLORECTAL CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
TAKEDA PHARM.CO.LTD. | 853849 | Frankfurt | 24,500 | 31.05.24 21:27:14 | +0,340 | +1,41% | 0,000 | 0,000 | 24,200 | 24,500 |
